ESI To Process Rxs Using Amazon Discount Coupons
Curiouser and curiouser….. There was a time when PBMs condemned the use of Rx discount coupons saying that doing so upsets the delicate balance of
January 28, 2022
Curiouser and curiouser….. There was a time when PBMs condemned the use of Rx discount coupons saying that doing so upsets the delicate balance of
We are always on the hunt for stories and events that can be impactful on the specialty pharmacy segment. The story below recently crossed out
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely
The FDA just approved not ONE, but TWO therapies in the already crowded immunology category. The two include a new NDA for Cibinqo (abrocitinib) from Pfizer and an expanded indication for
At the end of December, the FDA approved yet another biosimilar, Yusimry (adalimumab-aqvh) from Coherus Bioscience. Yusimry is a tumor necrosis factor blocker approved as
Last week the FDA approved a new ORAL therapy, Recorlev (levoketoconazole) from Xeris Biopharma Holdings, for the treatment of endogenous hypercortisolemia in adult patients with
We are catching up on the wave of FDA approvals that happen in the waning hours of the year. The FDA approved Apretude (cabotegravir), from
In the final hours of 2021, the FDA approved a number of new drugs. One of these therapies is Adbry (tralokinumab-ldrm) from Leo Pharma. Adbry,
Last week the FDA approved Leqvio, from Novartis Pharmaceuticals. Leqvio is a first-in-class, RNAi sub-Q therapy indicated as an adjunct to diet and maximally tolerated
The public relations battle surrounding White Bagging is heating up. Who’s on each side? Depends on who you ask….! On one side, hospitals are claiming that
